AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

AZATHIOPRINE

15 registrations across 4 African markets— 9 active

Markets with AZATHIOPRINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
ZAPRINE 50🇿🇦South AfricaSandoz South Africa (Pty) LtdsuspendedSept 2024
PHARM-AZATHIOPRINE🇿🇦South AfricaPharmacare Limited û WoodmeadsuspendedJul 2024
AZATHIOPRINE AQVIDA
Comprimé pelliculé / 50 mg
🇹🇳TunisiaAQVIDA GMBHexpiredJul 2018
IMUREK
Comprimé pelliculé / 50 mg
🇹🇳TunisiaASPEN PHARMA TRADING LimitedexpiredJul 2018
AZATHIOPRINE MYLAN
Comprimé pelliculé sécable / 50 mg
🇹🇳TunisiaMYLAN S.A.SexpiredApr 2014
IMUREL
Comprimé pelliculé / 50 mg
🇹🇳TunisiaAspen Europe GmbHexpiredMay 2013
AZATHIOPRINE 50 PCH🇿🇦South AfricaTeva Pharmaceuticals (Pty) LtdactiveNov 2011
AZAPRESS🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
IMURAN🇿🇦South AfricaPharmacare Limited û WoodmeadactiveJan 1900
IMUREL
COMPRIME PELLICULE
🇲🇦Moroccoactive
IMUREL
comprimé / 50 mg
🇸🇳SenegalASPENactive
IMUREL
comprimé / 25MG
🇸🇳Senegalactive
IMUREL
comprimé / 25MG
🇸🇳Senegalactive
IMUREL
COMPRIME PELLICULE
🇲🇦Moroccoactive
IMUREL
comprimé / 50 mg
🇸🇳SenegalASPENactive

AZATHIOPRINE in Africa — Regulatory Overview

AZATHIOPRINE is registered across 4 African markets with 15 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Senegal, Tunisia, Morocco. AfricaRegulatory refreshes this data daily from official government sources.

Of the 15 registrations, 9 (60%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.